Asset
METHYLSAMIDORPHAN CHLORIDE
Revenue
No revenue reported in loaded filings.
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01100151 | phase2 | completed | 2010-04-01 | 2010-12-01 | Alkermes, Inc. | ALK37-003: A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation (OIC) |
| NCT01382797 | phase2 | completed | 2011-08-01 | 2012-04-01 | Alkermes, Inc. | ALK37-005: A Study of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC) |
| NCT01418092 | phase2 | completed | 2011-09-01 | 2012-06-01 | Alkermes, Inc. | ALK37-007: Evaluation of Safety and Efficacy of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC) |
FDA applications (0)
This company has no applications containing this asset.